Boston’s Q2 shows that the startup rebound isn’t ahead of us, it’s upon us
The coronavirus caused some disagreement amongst Boston’s venture capital community. Looking back at our mid-2020 survey of its VCs, some saw the city’s strength in biotech and healthcare as a… »